NEW YORK, Aug. 28, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed in the United States District Court of the District Court of New Jersey against Vitamin Shoppe, Inc. ("Vitamin Shoppe" or the "Company") (NYSE: VSI) and certain of its officers, on behalf of a class consisting of investors who purchased Vitamin Shoppe securities between March 1, 2017 and August 6, 2017, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/vsi.
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
On May 10, 2017, Vitamin Shoppe revealed a 45% reduction in its FY17 EPS guidance. Then on August 9, 2017, Vitamin Shoppe said it was taking a $168 million goodwill impairment charge and would report a GAAP loss of $6.73 per share in the second quarter of 2017.
Earlier, on March 1, 2017, Vitamin Shoppe advised investors that it was on track to deliver "fully diluted earnings per share in the range of $1.95 - $2.20" for FY17. Then on March 1, 2017, Vitamin Shoppe stock closed at $21.35. Since then, Vitamin Shoppe has dropped dramatically, and closed at $6.05 per share on August 16, 2017.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/vsi or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Vitamin Shoppe you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.